Shots:
- The global nutraceutical market is advancing through preventive healthcare, personalized nutrition, probiotics, sports nutrition, and healthy ageing solutions. In 2025, Nestlé led the industry with $18.1B in nutraceutical revenue, followed by Danone ($10.91B) and Abbott Nutrition ($8.45B), reflecting strong demand for science-backed wellness products
- Valued at $636.2B in 2025, the global nutraceutical market is projected to reach $1.15T by 2033 with a CAGR of 7.7%. The Top 20 Nutraceutical Companies of 2026 ranking is based on nutraceutical segment revenue generated between January and December 2025, with revenues standardized into US dollars using year-end exchange rates
- This report highlights industry leaders driving innovation across dietary supplements, medical nutrition, probiotics, functional ingredients, and personalized wellness solutions. Key trends include precision nutrition, gut health, plant-based products, AI-enabled wellness platforms, and strategic acquisitions reshaping the market
20. Nu Skin
Total Revenue: $0.68B
Founded Year: 1984
Total Employees: 3,100
Headquarters: Utah, United States
Market Cap: $264.11M
Stock Exchange: NYSE
Ticker: NUS
- Nu Skin Enterprises is a global beauty and wellness company operating through its Wellness, Beauty, and Connected Device businesses. The company markets nutritional supplements, personal care products, and beauty devices through a direct-selling model across the Americas, Asia-Pacific, Europe, Africa, and Greater China
- Revenue declined from $0.75B in 2024 to $0.68B in 2025, representing a decrease of approximately 9.3%. The decline was primarily driven by a 0.8% negative impact from foreign-currency fluctuations, coupled with lower distributor engagement, as customers decreased 10%, paid affiliates declined 11%, and sales leaders fell 19% year-over-year by the end of 2025. Key nutraceutical products include the ageLOC TR90 weight-management system, LifePak nutritional supplements, Pharmanex dietary supplements, and g3 antioxidant beverage
- In April 2026, Nu Skin launched Prysm iO, an AI-powered wellness platform that assesses carotenoid antioxidant levels and delivers personalized nutritional recommendations, strengthening the company’s precision nutrition and digital wellness portfolio
19. Meiji Holdings
Total Revenue: $0.74B
Founded Year: 2009
Total Employees: 17,200
Headquarters: Chuo city, Tokyo Japan
Market Cap: $6.55B
Stock Exchange: TYO
Ticker: 2269
- Meiji Holdings is a leading Japanese food and health company operating across Dairy, Chocolate & Confectionery, Nutrition, and Food Solutions businesses. Its nutraceutical and nutrition portfolio is concentrated within the Nutrition segment, which includes infant formula, sports nutrition, high-nutrition foods, and overseas nutrition products
- Nutrition segment revenue declined from approximately $0.83B in 2024 to $0.74B in 2025, representing a decrease of about 10.8%. The decline was primarily attributed to lower overall sales in the nutrition business, driven by reduced inbound demand for infant formula in Japan and weaker export sales in overseas markets. Key nutraceutical products include SAVAS protein and sports nutrition products, infant formula, enteral nutrition products, and MICHITAS nutritional supplements for seniors
- In February 2026, Meiji and Fujitsu launched pilot project towards the social implementation of rRAFU indicator to predict future risks of malnutrition and frailty
18. USANA Health Sciences
Total Revenue: $0.8B
Founded Year: 1992
Total Employees: 1,600
Headquarters: Utah, United States
Market Cap: $366.86M
Stock Exchange: NYSE
Ticker: USNA
- USANA Health Sciences is a global health and wellness company focused on nutritional supplements, functional foods, and personal care products. The company operates through its Core Nutritional, Hiya, and Rise Wellness segments, serving customers across the Americas, Asia-Pacific, and Europe through direct selling and omnichannel distribution models
- Revenue increased from $0.74B in 2024 to $0.80B in 2025, reflecting growth of approximately 8.1%. The improvement was driven by higher sales within the nutraceutical business, supported by strong demand for nutritional products and contributions from its expanding wellness portfolio. Key nutraceutical products include CellSentials, Proflavanol C100, BiOmega, Probiotic, MagneCal D, and USANA Vitamin D supplements
- In April 2026, USANA Malaysia launched a new Vitamin D supplement alongside a nationwide wellness campaign and record-breaking community jogging event
17. Jamieson Wellness
Total Revenue: $0.82B
Founded Year: 1922
Total Employees: 1,346
Headquarters: Toronto, Canada
Market Cap: $1.06B
Stock Exchange: TSE
Ticker: JWEL
- Jamieson Wellness is a leading Canadian health and wellness company focused on vitamins, minerals, supplements, sports nutrition, probiotics, and natural health products. Through its Jamieson Brands and Strategic Partners segments, the company markets a broad portfolio of consumer wellness products across Canada, the United States, China, and other international markets
- Revenue increased from $0.73B in 2024 to $0.82B in 2025, reflecting growth of approximately 12.3%. The increase was driven by higher overall sales across the company’s health and wellness portfolio, supported by strong consumer demand and continued expansion in international markets. Key nutraceutical products include Jamieson vitamins and minerals, omega-3 supplements, probiotics, immunity products, magnesium supplements, collagen products, and youtheory branded wellness supplements
- In March 2026, Jamieson continued to advance its China growth strategy through its partnership with DCP Capital, originally established in May 2023. Under the agreement, DCP invested USD 35M for a 33% minority stake in the company’s China operations, providing capital to support market expansion. The arrangement includes multiple exit options, including Jamieson’s right to repurchase DCP’s stake between the fourth and fifth anniversary of the agreement at a predetermined revenue-based valuation, underscoring the company’s long-term commitment to strengthening its nutraceutical presence in China
16. Health and Happiness (H&H) International Holdings
Total Revenue: $1.74B
Founded Year: 1999
Total Employees: 2,800
Headquarters: Quarry Bay, Hong Kong
Market Cap: $0.89B
Stock Exchange: HKG
Ticker: BTSDF
- Health and Happiness (H&H) International Holdings Limited is a global nutrition company operating through its Baby Nutrition & Care (BNC), Adult Nutrition & Care (ANC), and Pet Nutrition & Care segments, with brands spanning infant nutrition, vitamins, supplements, and wellness products
- Revenue increased from $1.51B in 2024 to $1.74B in 2025, up 15.2%. Growth was driven by higher sales in both the ANC and BNC segments. Key nutraceutical brands/products include Swisse, Biostime, probiotics, vitamins, omega-3 supplements, and infant formula
- In Q1 2026, H&H reported 60.9% growth in Baby Nutrition & Care revenue and a 74.4% increase in infant formula sales in China, supported by the launch of a new HMO-containing infant formula and continued strong demand for nutritional supplements
15. International Flavors & Fragrances
Total Revenue: $2.28B
Founded Year: 1958
Total Employees: 22,400
Headquarters: New York, United States
Market Cap: $19.79B
Stock Exchange: NYSE
Ticker: IFF
- International Flavors & Fragrances is a global leader in specialty ingredients, operating through the Nourish, Health & Biosciences, Scent, and Pharma Solutions segments. Its nutraceutical portfolio includes functional ingredients, probiotics, proteins, enzymes, cultures, and health-focused food solutions
- Revenue increased from $2.20B in 2024 to $2.28B in 2025, reflecting growth of approximately 3.6%. The increase was driven by higher sales across both the Nourish and Health & Biosciences segments. Key nutraceutical products include HOWARU probiotics, Danisco cultures, plant proteins, dietary fibers, enzymes, and specialty health ingredients
- In March 2026, IFF secured the first heart health claim for isolated soy protein in Australia and New Zealand, enabling food and beverage manufacturers to promote the cholesterol-lowering benefits of soy protein and expand heart-health-focused nutrition products in the region
14. Bellring Brands
Total Revenue: $2.32B
Founded Year: 2019
Total Employees: 500
Headquarters: Missouri, United States
Market Cap: $1.04B
Stock Exchange: NYSE
Ticker: BRB
- BellRing Brands is a leading sports nutrition company focused on ready-to-drink protein shakes, protein powders, and nutrition bars. The company markets its products primarily through the Premier Protein and Dymatize brands
- Revenue increased from $2.09B in 2024 to $2.32B in 2025, representing growth of approximately 11.0%. The increase was driven by higher sales across all product categories, supported by strong consumer demand for convenient protein nutrition products. Key nutraceutical products include Premier Protein RTD shakes, Premier Protein powders and bars, and Dymatize sports nutrition supplements
- In Q2 2026 BellRing Brands reported net sales of $598.7M, driven by double-digit volume growth across its protein nutrition portfolio, including an 11.7% increase in Premier Protein RTD shake volumes
13. DSM-Firmenich
Total Revenue: $2.47B
Founded Year: 1902
Total Employees: 27,000
Headquarters: Kaiseraugst, Switzerland and Maastricht, Netherlands
Market Cap: $21.08B
Stock Exchange: AMS
Ticker: DSFIR
- DSM-Firmenich is a global science-based company operating across Health, Nutrition & Care, Taste, Texture & Health, Perfumery & Beauty, and Animal Nutrition & Health. Its nutraceutical portfolio includes vitamins, HMOs, probiotics, enzymes, nutritional lipids, and specialty health ingredients
- Revenue declined from $2.95B in 2024 to $2.47B in 2025, representing a decrease of approximately 16.3%. The decline was primarily due to softer market conditions and customer destocking, which impacted demand across key nutrition and health businesses. Key nutraceutical products include human milk oligosaccharides (HMOs), vitamins, probiotics, omega-3 solutions, nutritional lipids, and specialty dietary ingredients
- In March 2026, DSM-Firmenich strengthened its nutrition portfolio in Asia by securing new regulatory approvals for its HMO ingredients, including 2′-FL and LNnT, enabling broader use of these science-backed infant nutrition ingredients across key Asian markets
12. Tate & Lyle
Total Revenue: $2.69B
Founded Year: 1921
Total Employees: 5,000
Headquarters: Central London, England
Market Cap: $3.33B
Stock Exchange: LON
Ticker: TATE
- Tate & Lyle is a leading ingredients company focused on sweetening, mouthfeel, fortification, and health & wellness solutions. Its nutraceutical portfolio includes dietary fibers, prebiotics, plant-based ingredients, and specialty nutrition solutions
- Revenue increased from $2.02B in 2024 to $2.69B in 2025, representing growth of approximately 33.2%. The increase was driven by strong sales growth in the Asia-Pacific and Europe, Middle East & Africa regions. Key nutraceutical products include PROMITOR dietary fiber, STA-LITE polydextrose fiber, TASTEVA stevia sweeteners, and prebiotic fiber ingredients
- In June 2026, Tate & Lyle announced that its dietary fiber portfolio received Nutrastrong Prebiotic Verified certification, validating the prebiotic benefits of key fiber ingredients and strengthening the company’s position in the gut health and functional nutrition market
11. Reckitt
Total Revenue: $2.85B
Founded Year: 1840
Total Employees: 36,200
Headquarters: Berkshire, United Kingdom
Market Cap: $39.43B
Stock Exchange: LON
Ticker: RKT
- Reckitt is a global consumer health and hygiene company operating through its Health, Hygiene, and Nutrition segments. Its nutraceutical portfolio includes vitamins, minerals, supplements, and specialty nutrition products
- Revenue increased from $2.69B in 2024 to $2.85B in 2025, reflecting growth of approximately 5.9%. Growth was driven by a 6.1% improvement in price/mix, partially offset by a 2.3% decline in volume. Key nutraceutical products include MegaRed, Airborne, Move Free, Neuriva, and Schiff vitamins and supplements
- In April 2026, Reckitt reported double-digit growth in its Vitamins, Minerals & Supplements (VMS) portfolio, supported by strong demand in China, and expanded its nutrition range with the launch of a new high-strength MegaRed product
10. Yakult Honsha
Total Revenue: $3.02B
Founded Year: 1935
Total Employees: 29,300
Headquarters: Tokyo, Japan
Market Cap: $5.12B
Stock Exchange: TYO
Ticker: 2267
- Yakult Honsha is a leading Japanese health food company specializing in probiotics, functional beverages, nutritional supplements, and pharmaceutical products. The company operates globally through its Food & Beverages and Healthcare businesses
- Revenue declined from $3.18B in 2024 to $3.02B in 2025, representing a decrease of approximately 5.0%. The decline was primarily due to lower overall sales across key markets. Key nutraceutical products include Yakult probiotic drinks, Yakult 1000, Y1000, probiotic supplements, and other functional health beverages
- In February 2026, Yakult Europe launched Yakult Vitals, a dairy-free fermented soy drink fortified with vitamin D, calcium, zinc, and magnesium, in the Netherlands, expanding its plant-based nutrition portfolio and supporting its European growth strategy
9. Otsuka
Total Revenue: $3.69B
Founded Year: 2008
Total Employees: 37,758
Headquarters: Tokyo, Japan
Market Cap: $34.5B
Stock Exchange: TYO
Ticker: 4578
- Otsuka Holdings is a diversified healthcare company operating through its Nutraceutical, Pharmaceutical, Consumer, and Other businesses. Its nutraceutical portfolio includes functional foods, beverages, supplements, and sports nutrition products
- Revenue increased from $3.53B in 2024 to $3.69B in 2025, reflecting growth of approximately 4.5%. The increase was driven by higher overall sales across the nutraceutical business. Key nutraceutical products include Pocari Sweat, Nature Made, Calorie Mate, SOYJOY, and Oronamin C
- In February 2026, Otsuka expanded its nutraceutical business through the opening of a new Pocari Sweat factory in Tianjin, China, aimed at meeting growing demand and strengthening its health and wellness presence in the region
8. Glanbia
Total Revenue: $3.94B
Founded Year: 1997
Total Employees: 5,000
Headquarters: Kilkenny, Ireland
Market Cap: $6.14B
Stock Exchange: FRA
Ticker: GL9
- Glanbia is a global nutrition company operating through its Health & Nutrition (H&N) and Dairy Nutrition (DN) segments. The company specializes in performance nutrition, vitamins, minerals, supplements, functional ingredients, and dairy-based nutrition solutions
- Revenue increased from $3.83B in 2024 to $3.94B in 2025, reflecting growth of approximately 2.9%. The increase was driven by higher sales across both the Health & Nutrition and Dairy Nutrition segments. Key nutraceutical products include Optimum Nutrition, Isopure, SlimFast, Nutramino, protein powders, vitamins, minerals, and specialty whey protein ingredients
- In April 2026, Glanbia reported 11.6% growth in Health & Nutrition revenue during Q1 2026, supported by double-digit volume growth across Active Nutrition, Functional Beverages, and Vitamins, Minerals & Supplements, while demand for its premium whey protein solutions remained strong
7. Archer Daniels Midland Company
Total Revenue: $4.18B
Founded Year: 1902
Total Employees: 44,000
Headquarters Chicago, United States
Market Cap: $38.03B
Stock Exchange: NYSE
Ticker: ADM
- Archer Daniels Midland Company is a global nutrition company operating through its Nutrition, Ag Services & Oilseeds, and Carbohydrate Solutions segments. Its nutraceutical portfolio includes flavors, functional ingredients, probiotics, proteins, and specialty nutrition solutions
- Revenue increased from $3.94B in 2024 to $4.18B in 2025, representing growth of approximately 6.1%. Growth was driven by strong demand in the Flavors business, particularly in high-value categories such as energy drinks and ready-to-drink beverages. Key nutraceutical products include probiotics, postbiotics, plant proteins, flavor solutions, botanical extracts, and specialty health ingredients
- In May 2026, ADM expanded its nutrition portfolio with the launch of new protein ingredient solutions, designed to meet growing demand for high-protein foods and beverages while supporting innovation in sports nutrition, functional nutrition, and wellness products
6. Givaudan
Total Revenue: $4.61B
Founded Year: 1895
Total Employees: 18,000
Headquarters: Vernier, Geneva
Market Cap: $36.34B
Stock Exchange: SWX
Ticker: GIVN
- Givaudan is a global leader in Taste & Wellbeing and Fragrance & Beauty solutions. Its nutraceutical portfolio includes functional ingredients, botanical extracts, cognitive health ingredients, and wellness-focused nutrition solutions
- Revenue increased from $4.15B in 2024 to $4.61B in 2025, reflecting growth of approximately 11.1% in US dollar terms. While reported revenue declined in Swiss francs (CHF) due to currency effects, the business delivered growth in US dollars. Key nutraceutical products include Cereboost American ginseng extract, botanical ingredients, functional wellness solutions, and health-focused flavor systemsIn
- September 2025, Givaudan partnered with a leading research organization to evaluate the performance of Cereboost, its American ginseng extract, in supporting cognitive health and mental performance, further strengthening its science-backed wellness and nutraceutical portfolio
5. Herbalife
Total Revenue: $5.03B
Founded Year: 1980
Total Employees: 8,500
Headquarters: California, United States
Market Cap: $1.26B
Stock Exchange: NYSE
Ticker: HLF
- Herbalife is a global health and wellness company specializing in weight management, sports nutrition, targeted nutrition, and wellness products. The company distributes its products through a direct-selling model across more than 90 markets worldwide
- Revenue increased from $4.99B in 2024 to $5.03B in 2025, reflecting growth of approximately 0.8%. The increase was primarily driven by higher sales of weight management products. Key nutraceutical products include Formula 1 Healthy Meal Nutritional Shake Mix, Herbalife24 sports nutrition products, protein supplements, vitamins, and targeted wellness solutions
- In April 2026, Herbalife expanded its personalized nutrition portfolio through a partnership with Bioniq, enabling customized supplement recommendations based on individual health data and strengthening the company’s precision nutrition offerings
4. BASF SE
Total Revenue: $7.65B
Founded Year: 1865
Total Employees: 1,06,000
Headquarters: Rhineland-Palatinate, Germany
Market Cap: $50.59B
Stock Exchange: ETR
Ticker: BAS
- BASF SE is a global chemical and life sciences company operating through segments including Nutrition & Health, Agricultural Solutions, Industrial Solutions, and Materials. Its nutraceutical portfolio comprises vitamins, carotenoids, omega-3 ingredients, plant sterols, and specialty nutrition solutions
- Revenue increased from $7.00B in 2024 to $7.65B in 2025, representing growth of approximately 9.3% in US dollar terms. The increase was primarily driven by favorable currency exchange effects, while revenue showed a decline when reported in euros. Key nutraceutical products include vitamin A, vitamin E, carotenoids, omega-3 fatty acids, phytosterols, and human nutrition ingredients
- Last Year in BASF completed the sale of its Food and Health Performance Ingredients business to Louis Dreyfus Company (LDC) as part of its strategy to sharpen its Nutrition & Health portfolio and focus on high-growth areas such as vitamins and carotenoids for human and animal nutrition
3. Abbott Nutrition
Total Revenue: $8.45B
Founded Year: 1888
Total Employees: 1,15,000
Headquarters: Illinois, United States
Market Cap: $156.15B
Stock Exchange: NYSE
Ticker: ABT
- Abbott is a global healthcare company with a diversified portfolio spanning diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Its nutrition business includes science-based products across adult nutrition, pediatric nutrition, and specialized nutrition categories, designed to support growth, health, and healthy ageing.
- Revenue increased from $8.41B in 2024 to $8.45B in 2025, reflecting growth of approximately 0.5%. The increase was primarily driven by higher sales in International Adult Nutritionals. Key nutraceutical products include Ensure, Glucerna, PediaSure, Similac, and specialized nutritional supplements
- In May 2026, Abbott launched Ensure Strength Pro in India, a nutritional supplement formulated with 31 nutrients and 30 grams of high-quality protein to support seven key areas of health, including muscles, bones, heart, immunity, metabolism, blood cells, and the nervous system, targeting the nutritional needs of ageing adults
2. Danone
Total Revenue: $10.91B
Founded Year: 1919
Total Employees: 8 8,700
Headquarters: Paris, France
Market Cap: $51.98B
Stock Exchange: EPA
Ticker: BN
- Danone is a leading global nutrition company operating through its Specialized Nutrition, Essential Dairy & Plant-Based Products, and Waters segments. Its nutraceutical portfolio includes infant nutrition, medical nutrition, probiotics, and adult nutritional products
- Revenue increased from $9.30B in 2024 to $10.91B in 2025, representing growth of approximately 17.3%. The increase was driven by strong overall sales growth across the company’s nutrition and health-focused businesses. Key nutraceutical products include Aptamil, Nutricia, Fortimel, Neocate, Alpro, and specialized medical nutrition products
- In April 2026, Danone announced the acquisition of Huel, strengthening its position in the fast-growing healthy nutrition and meal replacement category. The transaction expands Danone’s portfolio in convenient, high-protein, and science-based nutrition solutions while enhancing its reach among health-conscious consumers
1. Nestle S.A.
Total Revenue: $18.1B
Founded Year: 1905
Total Employees: 2,71,000
Headquarters: Toronto, Canada
Market Cap: $256.32B
Stock Exchange: SWX
Ticker: NESN
- Nestlé S.A. is the world’s largest food and nutrition company, operating through Nutrition & Health Science, Dairy, Coffee, Pet Care, Confectionery, and Prepared Foods businesses. Its nutraceutical portfolio includes vitamins, supplements, medical nutrition, healthy ageing, and personalized nutrition products
- Revenue increased from $16.75B in 2024 to $18.10B in 2025, representing growth of approximately 8.1%. The increase was driven by strong overall sales growth across global markets. Key nutraceutical products include Garden of Life, Solgar, Pure Encapsulations, Vital Proteins, Boost, Resource, and Nutren nutritional products
- In February 2026, Nestlé scientists published new research demonstrating that NAD+ precursors (NR and NMN) can enhance cellular energy and support gut microbiome health, highlighting their potential role in healthy longevity
Criteria:
- The report is based on companies’ nutraceutical segment revenue for the period January to December 2025 only
- For Japanese companies or those with non-December fiscal year endings, revenue has been calculated for the January–December period using their quarterly filings
- Revenues reported in different currencies have been converted into US dollars using exchange rates as of 31 December 2025
Source:
- Company Websites
- Press Releases
- Annual Reports
- Quarterly Reports
- Google Finance
- OANDA
Related Post: Top 20 Nutraceutical Companies of 2025